A Multicenter, Multi-National, Open-Label, Single Group, Single and Multiple Dose Study of Foscan-Mediated Photodynamic Therapy (PDT) for the Palliative Treatment of Recurrent, Refractory or Second Primary Squamous Cell Carcinomas of the Head and Neck in Patients Considered to be Incurable With Surgery or Radiotherapy
Active, no longer recruiting
Phase of Trial: Phase II
Latest Information Update: 25 Jan 2016
At a glance
- Drugs Temoporfin (Primary)
- Indications Head and neck cancer
- Focus Therapeutic Use
- 18 Dec 2013 According to ClinicalTrials.gov, the recruitment status of this study is unknown because the information has not been verified recently' (last verified Jan 2001).
- 18 Sep 2005 New trial record.